Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study
更正:LTBK-01。AZD6244(Selumetinib)治疗复发或难治性儿童低级别胶质瘤的II期及再治疗研究的最新进展:一项儿童脑肿瘤联盟(PBTC)研究
期刊:Neuro-Oncology
影响因子:13.4
doi:10.1093/neuonc/noac029
Fangusaro, Jason R; Onar-Thomas, Arzu; Poussaint, Tina Young; Wu, Shengjie; Ligon, Azra H; Lindeman, Neal Ian; Banerjee, Anuradha; Packer, Roger; Kilburn, Lindsay B; Pollack, Ian F; Qaddoumi, Ibrahim A; Fisher, Paul Graham; Dhall, Girish; Baxter, Patricia Ann; Kreissman, Susan G; Doyle, L Austin; Smith, Malcolm A; Fouladi, Maryam; Dunkel, Ira J